372 related articles for article (PubMed ID: 8703650)
21. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of inhibition of wheal response to histamine by multiple doses of terfenadine.
Ryan WM
Ann Allergy; 1989 Dec; 63(6 Pt 2):609-11. PubMed ID: 2574553
[TBL] [Abstract][Full Text] [Related]
23. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
Simons FE; McMillan JL; Simons KJ
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):540-7. PubMed ID: 1977781
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
26. A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
Grant JA; Danielson L; Rihoux J; DeVos C
Int Arch Allergy Immunol; 1999; 118(2-4):339-40. PubMed ID: 10224437
[No Abstract] [Full Text] [Related]
27. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Takahashi H; Zhang Y; Morita E
Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947
[TBL] [Abstract][Full Text] [Related]
29. Peripheral H1-blockade effect of fexofenadine.
Simons FE; Simons KJ
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
[TBL] [Abstract][Full Text] [Related]
30. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
Pichat P; Angel I; Arbilla S
Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
[TBL] [Abstract][Full Text] [Related]
32. Suppression of epicutaneous reactivity by terfenadine and loratadine.
Small P
Ann Allergy; 1992 Jan; 68(1):30-4. PubMed ID: 1346563
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.
Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL
Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949
[TBL] [Abstract][Full Text] [Related]
34. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
Devalia JL; De Vos C; Hanotte F; Baltes E
Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
[TBL] [Abstract][Full Text] [Related]
36. Quantitative time course study of the skin response to histamine and the effect of H1 blockers. A 3-week crossover double-blind comparative trial of cetirizine and terfenadine.
Rihoux JP; Van Neste DJ
Dermatologica; 1989; 179(3):129-34. PubMed ID: 2574115
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin.
Clough GF; Boutsiouki P; Church MK
Allergy; 2001 Oct; 56(10):985-8. PubMed ID: 11576078
[TBL] [Abstract][Full Text] [Related]
38. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
39. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
Ballmer-Weber BK; Gex-Collet C; Wüthrich B
J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]